Improved generation of anti-tumor immunity by antigen dose limitation

BACKGROUND: The malignant cells of cutaneous T cell lymphoma (CTCL) display immunogenic peptides derived from the clonal T cell receptor (TCR) providing an attractive model for refinement of anti-tumor immunization methodology. To produce a clinically meaningful anti-tumor response, induction of cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Shofner, Joshua D, Vasquez, Juan G, Berger, Carole L, Edelson, Richard L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1800896/
https://www.ncbi.nlm.nih.gov/pubmed/17291350
http://dx.doi.org/10.1186/1476-8518-5-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1800896/
https://www.ncbi.nlm.nih.gov/pubmed/17291350
http://dx.doi.org/10.1186/1476-8518-5-2

Ejemplares similares